Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA updates statin labels

FDA approved several label changes for the statin class of cholesterol drugs, including eliminating the need for routine periodic monitoring

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE